What post‑procedural instructions should be given to patients after FDOPA (fluorodopa) and F‑18 NaTA (sodium taurocholate analog) PET/CT scans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Procedural Instructions After F-DOPA and F-18 NaTA PET/CT Studies

Patients should drink plenty of water and void frequently for 12 hours after their scan, with breastfeeding mothers needing to pump and discard milk for 24 hours.

Immediate Post-Scan Instructions

Hydration and Voiding (Critical for Radiation Safety)

The most important post-procedural instruction is aggressive hydration combined with frequent voiding to minimize radiation exposure to both the patient and others. 1

  • Void at 70 minutes post-injection (immediately before leaving the facility if imaging is complete)
  • Continue frequent voiding for 12 hours after tracer administration 1
  • Maintain hydration with water or other fluids as tolerated throughout the 12-hour period 1

The rationale is straightforward: the urinary bladder receives the highest radiation dose (0.30 mGy/MBq), and voiding 30 minutes after the scan reduces emitted radiation by approximately 22-35% beyond physical decay alone 2, 3. Research demonstrates that patients who void at 40 minutes post-injection have 50% lower bladder wall radiation doses compared to those voiding at 2 hours 1.

Radiation Precautions for Close Contacts

Limit close, prolonged contact with infants, young children, and pregnant women for 12 hours after the procedure. This is particularly important because approximately 75% of patients exceed 20 μSv/h when leaving the imaging facility 2.

Practical measures include:

  • Maintain distance (>1 meter) from vulnerable individuals when possible
  • Minimize holding infants or young children
  • Sleep in separate beds if sharing with a pregnant partner

Special Populations

Breastfeeding Mothers

Pump and discard all breast milk for at least 24 hours (12 half-lives) after F-DOPA administration 1. While little radiotracer is excreted in milk, the lactating breast accumulates the tracer, creating external radiation exposure risk to the nursing infant 4.

  • Feed the infant immediately before the scan to maximize time between injection and next feed
  • Use previously expressed milk or formula during the 24-hour period
  • Resume normal breastfeeding after 24 hours

Patients on Parkinson's Medications (F-DOPA specific)

If medications were held pre-scan, resume Parkinson's disease medications as prescribed after imaging is complete, unless otherwise instructed by the referring physician 1.

General Post-Scan Care

Activity Restrictions

  • No specific activity restrictions are required after the scan
  • Patients may resume normal diet immediately
  • Regular medications can be continued as prescribed

Diaper Changes (Pediatric Patients)

For children in diapers, change diapers promptly and frequently to minimize skin contact with radioactive urine. Dispose of diapers in regular trash (no special handling required for diagnostic doses) 5.

Common Pitfalls to Avoid

  1. Don't assume patients understand "drink plenty of fluids" - specify at least 1 liter over the next few hours
  2. Don't forget to emphasize the 24-hour breastfeeding interruption - this is longer than the 12-hour contact precaution and often confuses patients
  3. Don't overlook elderly or mobility-impaired patients who may have difficulty with frequent voiding - provide assistance or bedside commode access
  4. Don't discharge patients without ensuring they void at 70 minutes post-injection when possible

Note on F-18 NaTA Specificity

The provided evidence primarily addresses F-DOPA and general PET radiopharmaceutical safety. F-18 NaTA (sodium taurocholate analog) is a newer tracer with limited specific post-procedural guidance in the literature. Apply the same hydration and voiding protocols as for F-DOPA, as these represent standard radiation safety practices for all F-18 labeled compounds with urinary excretion.

References

Research

Reducing Radiation Exposure from PET Patients.

Journal of nuclear medicine technology, 2022

Guideline

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0.

European Journal of Nuclear Medicine and Molecular Imaging, 2015

Guideline

eanm procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine.

European Journal of Nuclear Medicine and Molecular Imaging, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.